Mildly elevated liver transaminase levels in the asymptomatic patient
- PMID: 15791889
Mildly elevated liver transaminase levels in the asymptomatic patient
Erratum in
- Am Fam Physician. 2005 Jul 1;72(1):41
Abstract
Mild elevations in liver chemistry tests such as alanine transaminase and aspartate transaminase can reveal serious underlying conditions or have transient and benign etiologies. Potential causes of liver transaminase elevations include viral hepatitis, alcohol use, medication use, steatosis or steatohepatitis, and cirrhosis. The history should be thorough, with special attention given to the use of medications, vitamins, herbs, drugs, and alcohol; family history; and any history of blood-product transfusions. Other common health conditions, such as diabetes, heart disease, and thyroid disease, can cause or augment liver transaminase elevations. The recent American Gastroenterological Association guideline regarding the evaluation and management of abnormal liver chemistry tests proposes a practical, algorithmic approach when the history and physical examination do not reveal the cause. In addition to liver chemistries, an initial serologic evaluation includes a prothrombin time; albumin; complete blood count with platelets; hepatitis A, B, and C serologies; and iron studies. Depending on the etiology, management strategies may include cessation of alcohol use, attention to medications, control of diabetes, and modification of lifestyle factors such as obesity. If elevations persist after an appropriate period of observation, further testing may include ultrasonography and other serum studies. In some cases, biopsy may be indicated.
Similar articles
-
Causes and evaluation of mildly elevated liver transaminase levels.Am Fam Physician. 2011 Nov 1;84(9):1003-8. Am Fam Physician. 2011. PMID: 22046940
-
[Interpretation of hypertransaminasemia].Tunis Med. 2002 May;80(5):236-44. Tunis Med. 2002. PMID: 12534025 Review. French.
-
Mildly Elevated Liver Transaminase Levels: Causes and Evaluation.Am Fam Physician. 2017 Dec 1;96(11):709-715. Am Fam Physician. 2017. PMID: 29431403
-
Special considerations in interpreting liver function tests.Am Fam Physician. 1999 Apr 15;59(8):2223-30. Am Fam Physician. 1999. PMID: 10221307 Review.
-
[Management of asymptomatic elevated serum aminotransferase levels, particularly in nonalcoholic steatohepatitis].Ned Tijdschr Geneeskd. 1999 Mar 6;143(10):506-9. Ned Tijdschr Geneeskd. 1999. PMID: 10321258 Review. Dutch.
Cited by
-
Real-World Evidence for COVID-19 Delta Variant's Effects on the Digestive System and Protection of Inactivated Vaccines from a Medical Center in Yangzhou, China: A Retrospective Observational Study.Int J Clin Pract. 2022 Aug 19;2022:7405448. doi: 10.1155/2022/7405448. eCollection 2022. Int J Clin Pract. 2022. PMID: 36052305 Free PMC article.
-
Effect of Coenzyme Q10 Supplementation in Statin-Treated Obese Rats.Biomol Ther (Seoul). 2016 Mar 1;24(2):171-7. doi: 10.4062/biomolther.2015.089. Biomol Ther (Seoul). 2016. PMID: 26797109 Free PMC article.
-
Targeted delivery of HSP90 inhibitors for efficient therapy of CD44-positive acute myeloid leukemia and solid tumor-colon cancer.J Nanobiotechnology. 2024 Apr 22;22(1):198. doi: 10.1186/s12951-024-02460-1. J Nanobiotechnology. 2024. PMID: 38649957 Free PMC article.
-
Safety Assessment of Liver Injury with Quetiapine Fumarate XR Management in Very Heavy Drinking Alcohol-Dependent Patients.Clin Drug Investig. 2016 Nov;36(11):935-944. doi: 10.1007/s40261-016-0439-2. Clin Drug Investig. 2016. PMID: 27503091 Free PMC article. Clinical Trial.
-
Diagnostic Modalities of Non-Alcoholic Fatty Liver Disease: From Biochemical Biomarkers to Multi-Omics Non-Invasive Approaches.Diagnostics (Basel). 2022 Feb 4;12(2):407. doi: 10.3390/diagnostics12020407. Diagnostics (Basel). 2022. PMID: 35204498 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical